An experimental coronavirus vaccine being developed by AstraZeneca and the University of Oxford was safe and produced an immune response in early-stage clinical trials, data showed, keeping alive the hope AZD1222 could be in use by the end of 2020.

The United Kingdom’s COVID-19 death toll exceeds 40,000, by far the worst yet reported in Europe, raising more questions about Prime Minister Boris Johnson’s handling of the coronavirus crisis.